Friday, March 22, 2013

Arsenical inducible the intersection of brain and the intersection of colloid and the intersection of tumour and cell wither lose prove

Arsenical inducible the intersection of brain and the intersection of colloid and the intersection of tumour and cell wither, lose, prove
A subsidiary institute nerve head of the department of surgery mere professor Zhao Shi of medical university of Kazakhstan heads the subject finished " Clear up the research and development of dosage form in genetic chip research and cranium of the impact on tumour cell of colloid of brain of arsenical slowly " ,Verify at home that oxidizes two arsenic (As2O3) three times in terms of animal's experiment for the first time Can induce the tumour cells of colloid of brain to wither and die; Develop the body of As2O3 lipid and clear up pharmaceuticals slowly independently at the same time, plant and start with the area of skill directly after colloid tumour excises the skill, have realized colloid tumour of brain is postoperative some to clear up chemotherapy slowly. This achievement obtained the scientific and technological progress first prize of medical and health of Heilongjiang Province a few days ago.
Brain the intersection of colloid and the intersection of tumour and department originate from the intersection of nerve and ectodermic tumour, malignant intensity high postoperative to recur while being easy, it recurs and usually lies in and sends the tumour position originally, so it is very essential to kill residual tumour cells effectively to improving the prognosis.
The main chemical composition of traditional Chinese medicine Arsenicum that As2O3 is, has already is used in the treatments of leukemia, lymphoma extensivelied and makes good curative effect. Zhao Shi only waits for someone and finds the hyperplasia that As2O3 can inhibit the cell department U87MG and T98G of colloid of brain from for the first time; On this basis, the seminar pursues the concrete mechanism that arsenical acts on colloid tumour of brain more deeply, developing has quality among clinical using value dosage form new in chemotherapy. The seminar still verifies As2O3 inhibits the cell hyperplasia of tumour and induces and withers to die by way of dosage reliance.
Our country's relevant domain expert opinion points out, this research results have advance and originality, having expanded resisting tumour table and medical value of As2O3, clinical application prospect is very broad. (Peak king's intelligent tip reporter Li LiYun of dawn of the clothing )
|

0 comments:

Post a Comment